BOSTON--(BUSINESS WIRE)--Feb. 3, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the following upcoming investor conferences:

• 17^th Annual BIO CEO & Investor Conference on Tuesday, February 10 at 1:30 p.m. ET at the Waldorf Astoria Hotel in New York City
• Leerink Global Healthcare Conference on Wednesday, February 11 at 1:00 p.m. ET at the Waldorf Astoria Hotel in New York City

Live audio webcasts of the presentations will be available on the company's website at www.verastem.com. Archived presentations will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation including FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

Source: Verastem, Inc.

Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com